DANA MCCABE: Open Payments
NPI 1003904293 · FORT CALHOUN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 24 payments from 10 companies in 2025. Trend: 2023 $462 · 2024 $257 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $85 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Novo Nordisk Inc | 3 | $59 |
| ABBVIE INC. | 2 | $39 |
| Astellas Pharma US Inc | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 5 | $23 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| PFIZER INC. | 1 | $16 |
| Amgen Inc. | 1 | $14 |
Products named: Wegovy, JARDIANCE, MOUNJARO, Veozah, VOQUEZNA, TEFLARO, AIRSUPRA, Ozempic.
Industry payments across NE — which companies pay providers there.
